Delivery Order SPE2DR25D2001-SPE2DR26FBFS5
- Not listed
- The Defense Logistics Agency awarded a $5,016.52 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Multaq 400 mg tablets (60-count units). This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with a completion date of December 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) valued at $1,573.44. The contract is firm fixed price with no set-aside designation, and was competitively awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,081.81 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Multaq 400 mg tablets (60-count). This firm fixed price contract, with an ultimate completion date of November 5, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Multaq 400 mg tablets (60-count) at a ceiling value of $1,588.89. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,418.56 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on October 15, 2025, with completion scheduled for October 16, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $37,333.81 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on July 15, 2025, with an ultimate completion date of July 16, 2025. The contract utilizes firm fixed pricing and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a $9,432.60 delivery order to AmerisourceBergen Drug Corp on April 28, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of April 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $17,446.83 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract with an ultimate completion date of August 19, 2025. This non-set-aside delivery order represents a single procurement action drawn from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $1,481.13 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) on November 13, 2025, with completion scheduled for November 14, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $5,759.04 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of 60-tablet bottles of Multaq 400 mg tablets, with completion scheduled for December 8, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing and represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. The order will be fulfilled from AmerisourceBergen's corporate office location in...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBFS5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,071.55 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on December 2, 2025, with an ultimate completion date of December 3, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency's Medical Supply Chain. The company supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with potential multiple awards across separate regions, positioning AmerisourceBergen to continue supporting military healthcare requirements through this flexible contracting framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 12/1/25 |